- Clinical Trials
- April 2025
- 80 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£966GBP
- Report
- January 2025
- 192 Pages
Global
From €2228EUR$2,500USD£1,933GBP
- Report
- August 2024
- 173 Pages
Global
From €2228EUR$2,500USD£1,933GBP
- Report
- January 2025
- 148 Pages
Global
From €2584EUR$2,900USD£2,242GBP
- Report
- January 2025
- 146 Pages
Global
From €2584EUR$2,900USD£2,242GBP
- Report
- June 2025
- 150 Pages
Global
From €2405EUR$2,699USD£2,086GBP
- Report
- June 2025
- 150 Pages
Global
From €2405EUR$2,699USD£2,086GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Report
- April 2025
- 218 Pages
Global
From €2228EUR$2,500USD£1,933GBP
- Report
- May 2025
- 150 Pages
Global
From €3431EUR$3,850USD£2,976GBP
- Report
- July 2025
- 50 Pages
Global
From €2361EUR$2,650USD£2,049GBP
- Report
- July 2025
- 50 Pages
Global
From €2361EUR$2,650USD£2,049GBP
- Report
- July 2025
- 50 Pages
Global
From €2361EUR$2,650USD£2,049GBP
- Report
- April 2025
- 155 Pages
Global
From €4451EUR$4,995USD£3,861GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Report
- February 2025
- 140 Pages
Global
From €4322EUR$4,850USD£3,749GBP
- Report
- January 2025
- 200 Pages
Global
From €4451EUR$4,995USD£3,861GBP
- Report
- November 2023
- 110 Pages
United States
From €4010EUR$4,500USD£3,479GBP

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive.
The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more